Gastric Cancer | Topics

 
CMG901 Granted Fast Track Designation by FDA in Unresectable or Metastatic Relapsed/Refractory Gastric and GEJ Cancer
April 27, 2022

Patients with unresectable or metastatic gastric or gastroesophageal junction cancer that is relapsed/refractory following other approved therapies may benefit from treatment with single-agent CMG901, which was granted fast track designation by the FDA.

Increased Rates of Occult Signet Ring Cell Gastric Cancer Seen in CDH1 P/LP Variant Carriers
March 25, 2022

Prospective data found higher rates of occult signet ring cell gastric cancer among individuals with no family history of gastric cancer but who carried CDH1 P/LP variants.

Laparoscopy Lead to Better OS, Noninferior RFS Vs Open Gastrectomy in Advanced Gastric Cancer
March 10, 2022

Laparoscopy compared with open gastrectomy was found to produce better overall survival outcomes at the 5-year follow-up analysis for patients with advanced gastric cancer.

TILs in Invasive Tumor Margins May Hold a Key to Gastric Cancer Prognosis
March 09, 2022

An analysis presented at 2022 IGCC showed that the level of CD8 + cells in the outer margin of gastric cancer tumors was significantly associated with survival outcomes and could inform prognosis.

Data Show Men With MSI-High Gastric Cancer Have Worse Survival Vs Female Counterparts
March 09, 2022

Men with MSI-high gastric cancer may have shorter overall survival than women, regardless of treatment modality.

Kohei Shitara, MD, Discusses Immunotherapy in Gastric Cancer at 2022 IGCC
March 08, 2022

Kohie Shitara, MD, spoke about the use of immunotherapy in the first-line setting for metastatic gastric cancer.

Low FAM46C Predictive of Inferior Survival Following Curative Resection for Gastric Adenocarcinoma
March 08, 2022

Post-resection survival could be predicted by FAM46C expression in patients with gastric adenocarcinoma.

Investigators Pool Data to Better Classify Prognosis in Gastric Tumor
March 08, 2022

In a presentation at 2022 IGCC, Ju-Seog Lee, PhD, discussed an analysis that combined tumor classification models to derive new prognostic subgroups in gastric cancer.

Benefit Seen With Laparoscopic Proximal Gastrectomy For Upper Third Early Gastric Cancer
March 07, 2022

Laparoscopic proximal gastrectomy led to less vitamin B12 supplement use than total gastrectomy without negatively impacting survival for upper third early gastric cancer.

Treating Frontline PD-L1+ Gastric/GEJ Adenocarcinoma With Pembrolizumab Monotherapy or Plus Chemo Results in Similar OS as SOC
January 21, 2022

Adding pembrolizumab to chemotherapy does not improve outcomes over chemotherapy alone in patients with advanced gastric or gastroesophageal junction adenocarcinoma, according to updated results of the KEYNOTE-062 trial.